Table 1. Biological, molecular and cytogenetic features of CLL patients included in the study.
Variable | N° of positive/investigated patients (%) | Correlation with TTFT |
ZAP-70 | 367/1011 (36.3%) | P<0.0001 |
CD38 | 306/1051 (29.1%) | P<0.0001 |
IGHV * | 405/1126 (36%) | P<0.0001 |
No FISH alteration ** | 238/704 (33.8%) | P<0.0001 |
Del(13)(q14) | 287/704 (40.7%) | |
Trisomy 12 | 98/704 (13.9%) | |
Del(11)(q23) | 46/704 (6.5%) | |
Del(17)(p13) | 35/704 (5%) |